Disclosed herein are methods of treating, preventing, and sensitizing cancer and/or reducing cellular proliferation in a patient, comprising administering a therapeutically effective amount of at least one cationic steroid antimicrobial (CSA), or a pharmaceutically acceptable salt thereof. Kits comprising such compositions and instructions on such methods are also contemplated herein.